The role of creatine kinase in inhibition of mitochondrial permeability transition
- PMID: 9315696
- DOI: 10.1016/s0014-5793(97)01045-4
The role of creatine kinase in inhibition of mitochondrial permeability transition
Abstract
Cyclosporin A sensitive swelling of mitochondria isolated from control mouse livers and from the livers of transgenic mice expressing human ubiquitous mitochondrial creatine kinase occurred in the presence of both 40 microM calcium and 5 microM atractyloside which was accompanied by a 2.5-fold increase over state 4 respiration rates. Creatine and cyclocreatine inhibited the latter only in transgenic liver mitochondria. Protein complexes isolated from detergent solubilised rat brain extracts, containing octameric mitochondrial creatine kinase, porin and the adenine nucleotide translocator, were reconstituted into malate loaded lipid vesicles. Dimerisation of creatine kinase in the complexes and exposure of the reconstituted complexes to >200 microM calcium induced a cyclosporin A sensitive malate release. No malate release occurred with complexes containing octameric creatine kinase under the same conditions.
Similar articles
-
Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore.FEBS Lett. 1996 Nov 4;396(2-3):189-95. doi: 10.1016/0014-5793(96)01092-7. FEBS Lett. 1996. PMID: 8914985
-
Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases.Biochim Biophys Acta. 1998 Jan 5;1368(1):7-18. doi: 10.1016/s0005-2736(97)00175-2. Biochim Biophys Acta. 1998. PMID: 9459579
-
Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase.Biochem J. 1990 May 15;268(1):153-60. doi: 10.1042/bj2680153. Biochem J. 1990. PMID: 2160810 Free PMC article.
-
The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition.Biofactors. 1998;8(3-4):235-42. doi: 10.1002/biof.5520080311. Biofactors. 1998. PMID: 9914825 Review.
-
Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage.Biol Signals Recept. 2001 Jan-Apr;10(1-2):93-111. doi: 10.1159/000046878. Biol Signals Recept. 2001. PMID: 11223643 Review.
Cited by
-
Pharmacological therapy in Parkinson's disease: focus on neuroprotection.CNS Neurosci Ther. 2011 Oct;17(5):345-67. doi: 10.1111/j.1755-5949.2010.00150.x. Epub 2010 Apr 23. CNS Neurosci Ther. 2011. PMID: 20438581 Free PMC article. Review.
-
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.J Cell Mol Med. 2011 Apr;15(4):701-17. doi: 10.1111/j.1582-4934.2010.01237.x. J Cell Mol Med. 2011. PMID: 21155972 Free PMC article. Review.
-
The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins.J Exp Med. 1998 Apr 20;187(8):1261-71. doi: 10.1084/jem.187.8.1261. J Exp Med. 1998. PMID: 9547337 Free PMC article.
-
Increasing creatine kinase activity protects against hypoxia / reoxygenation injury but not against anthracycline toxicity in vitro.PLoS One. 2017 Aug 14;12(8):e0182994. doi: 10.1371/journal.pone.0182994. eCollection 2017. PLoS One. 2017. PMID: 28806770 Free PMC article.
-
Current perspective of mitochondrial biology in Parkinson's disease.Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14. Neurochem Int. 2018. PMID: 29550604 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
